Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double-blind placebo-controlled trial JHM IRB

Primary Objective

To investigate the use of Orilissa to treat endometriosis prior to in-vitro fertilization procedures.

Is This Study For You?

Let's Get Started!

Description

This study is looking for women with endometriosis that are about to start in-vitro fertilization procedures to see how Orilissa, a drug to help with symptoms of endometriosis, affects fertility treatment. Participants can expect up to 5 study visits spanning over approximately 6 months, entailing a 60-day drug period and the fertility treatment itself. You must be willing to take a medication and undergo blood draws, fertility treatments, and assessments.

Details
Age
Adult
Eligibility
Ages: 18-38 years old Must have confirmed diagnosis of endometriosis Must be planning IVF for treatment of infertility
Locations

Outpatient CTRC
SGF Colorado - Colorado Springs
SGF Colorado - Denver

Principal Investigator
Photograph of Nanette Santoro

Nanette Santoro

Study ID

Protocol Number: 19-3115

More information available at ClinicalTrials.gov: NCT04173169

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers